Immunogen Inc (IMGN)

6.62 -0.54  -7.54% NASDAQ Dec 3, 16:00 6.64 +0.02  +0.30% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All IMGN News

News

View All Events

Events

Date Type Description
02/11/2022 Earnings Results Q4 2021 Earnings Results
02/11/2022 08:00 EST Earnings Calls Q4 2021 Earnings Call
10/29/2021 Earnings Results Q3 2021 Earnings Results
10/29/2021 08:00 EST Earnings Calls Q3 2021 Earnings Call
07/30/2021 Earnings Results Q2 2021 Earnings Results
07/30/2021 08:00 EST Earnings Calls Q2 2021 Earnings Call
06/16/2021 09:00 EST AGM 2020 Annual General Meeting
05/10/2021 Earnings Results Q1 2021 Earnings Results
05/10/2021 08:00 EST Earnings Calls Q1 2021 Earnings Call
02/12/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent. The technology is used in Kadcyla (ado-trastuzumab emtansine)--a registered trademark of Genentech, a member of the Roche Group--to kill solid tumors. Companies such as Amgen, Genentech/Roche, Lilly, Novartis, Sanofi, and Takeda have licensed limited rights to use the ADC technology in their therapies.
  • URL: https://www.immunogen.com
  • Investor Relations URL: https://investor.immunogen.com
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Feb. 11, 2022
  • Last Earnings Release: Oct. 29, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
SMHCLX ST Healthcare Innovations 12 RE 2.89%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.